DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Norpramin (Desipramine Hydrochloride) - Published Studies


Norpramin Related Published Studies

Well-designed clinical trials related to Norpramin (Desipramine)

Pharmacokinetic and pharmacodynamic interactions between almorexant, a dual orexin receptor antagonist, and desipramine. [2014]

Oral desipramine and topical lidocaine for vulvodynia: a randomized controlled trial. [2010.09]

Oral desipramine and topical lidocaine for vulvodynia: a randomized controlled trial. [2010]

A double-blind, multicenter, parallel-group study of paroxetine, desipramine, or placebo in breast cancer patients (stages I, II, III, and IV) with major depression. [2006.02]

Desipramine treatment of cocaine-dependent patients with depression: a placebo-controlled trial. [2005.11.01]

Comparative effects of duloxetine and desipramine on sleep EEG in healthy subjects. [2005.02]

Desipramine treatment for cocaine dependence in buprenorphine- or methadone-treated patients: baseline urine results as predictor of response. [2005.01]

Effects of desipramine and escitalopram on postprandial symptoms induced by the nutrient drink test in healthy volunteers: a randomized, double-blind, placebo-controlled study. [2005]

Modulating sensorimotor gating in healthy volunteers: the effects of desipramine and haloperidol. [2004.07.15]

Depression predicts higher rates of heroin use on desipramine with buprenorphine than with methadone. [2004.03]

Effect of the novel anxiolytic drug deramciclane on cytochrome P(450) 2D6 activity as measured by desipramine pharmacokinetics. [2004.02]

Effects of methylphenidate, desipramine, and L-dopa on attention and inhibition in children with Attention Deficit Hyperactivity Disorder. [2003.10.17]

Comorbid major depressive disorder as a prognostic factor in cocaine-abusing buprenorphine-maintained patients treated with desipramine and contingency management. [2003.08]

Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders. [2003.07]

Desipramine and contingency management for cocaine and opiate dependence in buprenorphine maintained patients. [2003.06.05]

Effects of reducing contingency management values on heroin and cocaine use for buprenorphine- and desipramine-treated patients. [2003.05]

Comparison of desipramine or carbamazepine to placebo for crack cocaine-dependent patients. [2003.03]

The effect of chronic oral desipramine on capsaicin-induced allodynia and hyperalgesia: a double-blinded, placebo-controlled, crossover study. [2002.10]

The SSRIs drug Fluoxetine, but not the noradrenergic tricyclic drug Desipramine, improves memory performance during acute major depression. [2002.08.15]

Double-blind study of high-dose fluoxetine versus lithium or desipramine augmentation of fluoxetine in partial responders and nonresponders to fluoxetine. [2002.08]

A double-blind comparison of desipramine and placebo in children and adolescents with chronic tic disorder and comorbid attention-deficit/hyperactivity disorder. [2002.07]

Utility of crossover designs in clinical trials: efficacy of desipramine vs. placebo in opioid-dependent cocaine abusers. [2002.03]

Cerebral blood flow in obsessive-compulsive patients with major depression: effect of treatment with sertraline or desipramine on treatment responders and non-responders. [2001.11.30]

Comparison of desipramine and cognitive/behavioral therapy in the treatment of elderly outpatients with mild-to-moderate depression. [2001.06]

Multicenter double-blind comparison of sertraline and desipramine for concurrent obsessive-compulsive and major depressive disorders. [2000.01]

Effect of tolcapone on the haemodynamic effects and tolerability of desipramine. [2000]

Clomipramine vs desipramine crossover trial in body dysmorphic disorder: selective efficacy of a serotonin reuptake inhibitor in imagined ugliness. [1999.11]

Desipramine in opioid-dependent cocaine abusers maintained on buprenorphine vs methadone. [1999.09]

Comparison of the effects of venlafaxine, desipramine, and paroxetine on noradrenaline- and methoxamine-evoked constriction of the dorsal hand vein. [1999.09]

Tryptophan-depletion challenge in depressed patients treated with desipramine or fluoxetine: implications for the role of serotonin in the mechanism of antidepressant action. [1999.07.15]

Comparison of the effects of venlafaxine, paroxetine and desipramine on the pupillary light reflex in man. [1999.04]

A double-blind crossover comparison of clomipramine and desipramine in the treatment of panic disorder. [1999.03]

Double-blind comparison of fluoxetine and desipramine in the treatment of depressed women with advanced HIV disease: a pilot study. [1999]

Lithium and desipramine versus desipramine alone in the treatment of severe major depression: a preliminary study. [1998.09]

A controlled trial of fluoxetine and desipramine in depressed women with advanced cancer. [1998.07]

Antidepressant treatment of chronic tension-type headache: a comparison between fluoxetine and desipramine. [1998.07]

Adolescent depression: controlled desipramine treatment and atypical features. [1998]

Addition of desipramine to serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder. [1997.09]

The effect of sertraline on the pharmacokinetics of desipramine and imipramine. [1997.08]

Desipramine pharmacokinetics when coadministered with paroxetine or sertraline in extensive metabolizers. [1997.08]

Effect of ketoconazole on the pharmacokinetics of imipramine and desipramine in healthy subjects. [1997.03]

Concurrent treatment of nonresistant major depression with desipramine and lithium: a double-blind, placebo-controlled study. [1997.02]

Maintenance therapy for chronic depression. A controlled clinical trial of desipramine. [1996.09]

Six-week, double-blind, placebo-controlled study of desipramine for adult attention deficit hyperactivity disorder. [1996.09]

Changes in thyroid hormone levels associated with desipramine response in adolescent depression. [1996.08]

A double-blind, placebo-controlled trial of desipramine for primary alcohol dependence stratified on the presence or absence of major depression. [1996.03.13]

Desipramine, amantadine, or fluoxetine in buprenorphine-maintained cocaine users. [1995.11]

Comparison of the effects of desipramine on noradrenaline- and methoxamine-evoked venoconstriction in man. [1995.11]

A double-blind comparison of clomipramine and desipramine in the treatment of developmental stuttering. [1995.06]

Retreatment for relapse following desipramine discontinuation in dysthymia. [1995.06]

Premenstrual syndrome: a double-blind controlled trial of desipramine and methylscopolamine. [1995.06]

The effect of desipramine on basal and naloxone-stimulated cortisol secretion in humans: interaction of two drugs acting on noradrenergic control of adrenocorticotropin secretion. [1995.03]

The treatment of attention-deficit hyperactivity disorder in Tourette's syndrome: a double-blind placebo-controlled study with clonidine and desipramine. [1995.01]

Effects of methylphenidate in HIV-related depression: a comparative trial with desipramine. [1995]

Continuity of care and desipramine in primary cocaine abusers. [1994.10]

A double-blind trial of bupropion versus desipramine for bipolar depression. [1994.09]

Response to desipramine treatment in adolescent depression: a fixed-dose, placebo-controlled trial. [1994.06]

Sympathetic nervous system activity in major depression. Basal and desipramine-induced alterations in plasma norepinephrine kinetics. [1994.05]

Pharmacokinetics of desipramine coadministered with sertraline or fluoxetine. [1994.04]

Desipramine treatment for cocaine dependence. Role of antisocial personality disorder. [1994.03]

Comparison of the effects of acute fluvoxamine and desipramine administration on melatonin and cortisol production in humans. [1994.02]

Post-stroke depression: combined treatment with imipramine or desipramine and mianserin. A controlled clinical study. [1994.02]

Comparison of cognitive-behavior therapy and desipramine in the treatment of bulimia nervosa. [1994.01]

Impact of desipramine or carbamazepine on patient retention in outpatient cocaine treatment: preliminary findings. [1994]

Fluoxetine and desipramine in major depressive disorder. [1993.10]

Side effects of methylphenidate and desipramine alone and in combination in children. [1993.09]

Central analgesic effects of desipramine, fluvoxamine, and moclobemide after single oral dosing: a study in healthy volunteers. [1993.09]

A double-blind comparison of clomipramine, desipramine, and placebo in the treatment of autistic disorder. [1993.06]

Temporal factors in the enhancement of morphine analgesia by desipramine. [1993.06]

Methylphenidate and desipramine in hospitalized children: I. Separate and combined effects on cognitive function. [1993.03]

A double-blind placebo controlled study of desipramine in the treatment of ADD: III. Lack of impact of comorbidity and family history factors on clinical response. [1993.01]

Effect of desipramine on cerebrospinal fluid concentrations of corticotropin-releasing factor in human subjects. [1993.01]

Preliminary report: placebo-controlled, double-blind study of the clinical and metabolic effects of desipramine in panic disorder. [1993]

Beta-receptor responsiveness after desipramine treatment. [1993]

Cortisol response to intramuscular desipramine in patients with major depression and normal control subjects: a replication study. [1992.12]

Pharmacotherapy for cocaine-abusing methadone-maintained patients using amantadine or desipramine. [1992.11]

Desipramine treatment of cocaine dependence in methadone-maintained patients. [1992.11]

Increased pulse and blood pressure associated with desipramine treatment of bulimia nervosa. [1992.06]

Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. [1992.05.07]

Lack of effect of desipramine on the response to chloroquine of patients with chloroquine-resistant falciparum malaria. [1992.05]

Differential response of seven subjects with autistic disorder to clomipramine and desipramine. [1992.03]

Treatment of cocaine dependence in methadone maintenance clients: a pilot study comparing the efficacy of desipramine and amantadine. [1992]

A double-blind desipramine substitution during long-term clomipramine treatment in children and adolescents with obsessive-compulsive disorder. [1991.10]

Comparison of amantadine and desipramine combined with psychotherapy for treatment of cocaine dependence. [1991.06]

Clinical and neuropsychological effects of desipramine in children with attention deficit hyperactivity disorder. [1991.06]

A comparison of adinazolam and desipramine in the treatment of major depression. [1991.06]

Efficacy of desipramine in painful diabetic neuropathy: a placebo-controlled trial. [1991.04]

Acute noradrenergic effects of desipramine in depression. [1991.02]

Fluvoxamine versus desipramine: comparative polysomnographic effects. [1991.01.01]

Desipramine treatment of alcoholism. [1991]

Response to desipramine treatment in adolescent major depression. [1991]

Clomipramine vs desipramine vs placebo in the treatment of diabetic neuropathy symptoms. A double-blind cross-over study. [1990.11]

The role of neuropharmacologic selectivity in antidepressant action: fluvoxamine versus desipramine. [1990.09]

A controlled trial of adinazolam versus desipramine in geriatric depression. [1990.07]

Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder. Comparison of fluvoxamine and desipramine. [1990.06]

Desipramine relieves postherpetic neuralgia. [1990.03]

Desipramine blocks augmented neurogenic vasoconstrictor responses to epinephrine. [1990.02]

Moclobemide (Ro 11-1163) versus desipramine in the treatment of endogenous depression. [1990]

Treatment of obsessive-compulsive disorder with clomipramine and desipramine in children and adolescents. A double-blind crossover comparison. [1989.12]

Bulimia: independence of antibulimic and antidepressant properties of desipramine. [1989.02]

Desipramine facilitation of initial cocaine abstinence. [1989.02]

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017